Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30047445HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047446HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047447HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047448HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047449HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047450HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS30047451HIVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TVIS20067557HPVENSG00000105355.9protein_codingPLIN3NoNo10226O60664
TCGA Plot Options
Drug Information
GenePLIN3
DrugBank IDDB01279
Drug NameGalsulfase
Target IDBE0000856
UniProt IDO60664
Regulation Type
PubMed IDs17016423; 18709516
CitationsImming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@White JT, Argento Martell L, Prince WS, Boyer R, Crockett L, Cox C, Van Tuyl A, Aguilera A, Foehr E: Comparison of neutralizing antibody assays for receptor binding and enzyme activity of the enzyme replacement therapeutic Naglazyme (galsulfase). AAPS J. 2008 Sep;10(3):439-49. doi: 10.1208/s12248-008-9048-1. Epub 2008 Aug 16.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164746235
ChEMBLCHEMBL1201822